Aeglea BioTherapeudics Inc. (NASDAQ:AGLE) up 70%

(NASDAQ: AGLE) shares have moved up in pre-market more than 70% as of this post to .84 off overnight highs of $1.19. The stock has traded more than 7 million in volume and has more than 25,000 trades heading into the open. The company announced the approval of a marketing plan. The 2-year highest trading day was around 11 million shares and the price during that session reached $3.0

RISK: This post is the author’s view of what’s happening and is not investment advice. The editors or others using this site can and will trade all stocks posted. Use this information at your own risk as you are responsible for your trading and losses. There is no guarantee any post will be updated and should be taken on an “as is basis” when posted. The market moves and changes quickly which makes the information contained in this post old very quickly.


Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist